TIL the end: Tracking T cell clonotype dynamics during adoptive cell therapy.

Immunity

Laboratory of Experimental Dermatology, Department of Dermatology, University Hospital and Health Campus Immunology Infectiology and Inflammation (GC-I3), Otto-von-Guericke-University, Magdeburg, Germany. Electronic address:

Published: October 2024

AI Article Synopsis

  • - The study focuses on identifying factors that enhance the effectiveness of adoptive cell therapies using tumor-infiltrating lymphocytes (TIL-ACT) to optimize treatment methods.
  • - Chiffelle et al. conduct an in-depth comparison of CD8 T cell clonotypes, examining their behavior in patients who respond well to the therapy versus those who do not.
  • - Insights from this research aim to improve understanding of TIL-ACT responses, potentially leading to better therapeutic strategies for cancer treatment.

Article Abstract

Understanding the factors that lead to the therapeutic success of adoptive cell therapies using tumor-infiltrating lymphocytes (TIL-ACT) will improve current treatment protocols. In this issue of Immunity, Chiffelle et al. comprehensively compare the dynamics of CD8 T cell clonotypes during the course of ACT between responding and non-responding patients.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.immuni.2024.09.012DOI Listing

Publication Analysis

Top Keywords

adoptive cell
8
tracking t cell
4
t cell clonotype
4
clonotype dynamics
4
dynamics adoptive
4
cell therapy
4
therapy understanding
4
understanding factors
4
factors lead
4
lead therapeutic
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!